Literature DB >> 28630175

Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy.

Yingxin Li1, Karim Sallam1, Peter J Schwartz1, Joseph C Wu2.   

Abstract

Entities:  

Keywords:  Editorials; cardiovascular diseases; induced pluripotent stem cells; myocytes, cardiac; ryanodine receptor calcium release channel; stem cells

Mesh：

Substances：

Year:  2017        PMID： 28630175      PMCID： PMC5517015          DOI： 10.1161/CIRCEP.117.005398

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


× No keyword cloud information.
  21 in total

Review 1.  Do animal models have clinical value?

Authors:  P J Schwartz
Journal:  Am J Cardiol       Date:  1998-03-19       Impact factor: 2.778

Review 2.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Karim Sallam; Yingxin Li; Philip T Sager; Steven R Houser; Joseph C Wu
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

3.  Stem cells: disease models that show and tell.

Authors:  Vivien Marx
Journal:  Nat Methods       Date:  2015-01-29       Impact factor: 28.547

Review 4.  Modeling inherited cardiac disorders.

Authors:  Karim Sallam; Kazuki Kodo; Joseph C Wu
Journal:  Circ J       Date:  2014-03-17       Impact factor: 2.993

5.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Christian van der Werf; Prince J Kannankeril; Frederic Sacher; Andrew D Krahn; Sami Viskin; Antoine Leenhardt; Wataru Shimizu; Naokata Sumitomo; Frank A Fish; Zahurul A Bhuiyan; Albert R Willems; Maurits J van der Veen; Hiroshi Watanabe; Julien Laborderie; Michel Haïssaguerre; Björn C Knollmann; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2011-05-31       Impact factor: 24.094

6.  Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.

Authors:  Ping Liang; Karim Sallam; Haodi Wu; Yingxin Li; Ilanit Itzhaki; Priyanka Garg; Ying Zhang; Vittavat Vermglinchan; Feng Lan; Mingxia Gu; Tingyu Gong; Yan Zhuge; Chunjiang He; Antje D Ebert; Veronica Sanchez-Freire; Jared Churko; Shijun Hu; Arun Sharma; Chi Keung Lam; Melvin M Scheinman; Donald M Bers; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-11-08       Impact factor: 24.094

7.  Modeling human disease with pluripotent stem cells: from genome association to function.

Authors:  Florian T Merkle; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2013-06-06       Impact factor: 24.633

8.  Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation.

Authors:  Gaetano M De Ferrari; Veronica Dusi; Carla Spazzolini; J Martijn Bos; Dominic J Abrams; Charles I Berul; Lia Crotti; Andrew M Davis; Michael Eldar; Maria Kharlap; Asaad Khoury; Andrew D Krahn; Antoine Leenhardt; Christopher R Moir; Attilio Odero; Louise Olde Nordkamp; Thomas Paul; Ferran Rosés I Noguer; Maria Shkolnikova; Jan Till; Arthur A M Wilde; Michael J Ackerman; Peter J Schwartz
Journal:  Circulation       Date:  2015-05-27       Impact factor: 29.690

9.  The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome.

Authors:  Peter J Schwartz; Carla Spazzolini; Lia Crotti; Jørn Bathen; Jan P Amlie; Katherine Timothy; Maria Shkolnikova; Charles I Berul; Maria Bitner-Glindzicz; Lauri Toivonen; Minoru Horie; Eric Schulze-Bahr; Isabelle Denjoy
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

Review 10.  Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.

Authors:  Ian Y Chen; Elena Matsa; Joseph C Wu
Journal:  Nat Rev Cardiol       Date:  2016-03-24       Impact factor: 32.419
View more
  4 in total

Review 1.  Atrial Fibrillation in Inherited Channelopathies.

Authors:  Baha'a Al-Azaam; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2021-01-08

2.  Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome.

Authors:  Glen Lester Sequiera; Abhay Srivastava; Keshav Narayan Alagarsamy; Cheryl Rockman-Greenberg; Sanjiv Dhingra
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

3.  hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells.

Authors:  Disheet Shah; Chandra Prajapati; Kirsi Penttinen; Reeja Maria Cherian; Jussi T Koivumäki; Anna Alexanova; Jari Hyttinen; Katriina Aalto-Setälä
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

4.  A human population-based organotypic in vitro model for cardiotoxicity screening.

Authors:  Fabian A Grimm; Alexander Blanchette; John S House; Kyle Ferguson; Nan-Hung Hsieh; Chimeddulam Dalaijamts; Alec A Wright; Blake Anson; Fred A Wright; Weihsueh A Chiu; Ivan Rusyn
Journal:  ALTEX       Date:  2018-07-08       Impact factor: 6.043
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.